Bristol Myers Squibb Unveils $2 Billion Cost-Cutting Strategy Amid Patent Expirations and Market Challenges February 6, 2025
Declining Sales and Strategic Shifts: The Evolving Landscape of RSV Vaccination Amidst Regulatory Changes February 6, 2025
Navigating the Storm: How Revised CDC Guidelines Dampen RSV Vaccine Sales for GSK and Pfizer February 6, 2025
Kennedy’s Controversial Path to HHS: Commitments to Vaccine Safety Win Key Senate Support February 5, 2025
Kennedy’s Health Nomination Advances: Cassidy Secures Key Commitments on Vaccine Oversight Kennedy’s Health Nomination Advances: Cassidy Secures Key Commitments on Vaccine Oversight February 4, 2025
